BioMelbourne Network
Progressing BioIndustry
Latest News
Acrux Loses Founder, Director Prof Barrie Finnin
4 September 2011
Acrux says co-founder Prof Barrie Finnin has retired as a director after 12 years’ service to the company.
Acrux said Prof Finnin was a co-inventor of its transdermal drug delivery technology and he played an integral role in developing the core technology and the company’s corporate growth.
Acrux said it would appoint a suitably qualified non-executive director to replace Prof Finnin in due course.
Acrux was up nine cents or 2.3 percent to $3.93 with 1.3 million shares traded.
